Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Neumann

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Cell Calcium|November 28, 2025
Fura-10, unlike fura-2, is suitable for long-term calcium imaging in natural killer (NK) cells without compromising cytotoxicity and can be combined with target cell death analysisLea Kaschek, Joanne Vialle, Gebhard Stopper, et al.
Plos One|September 7, 2022
Your best day: An interactive app to translate how time reallocations within a 24-hour day are associated with health measuresDorothea Dumuid, Timothy Olds, Melissa Wake, et al.
JAMA Oncology|July 17, 2015
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical TrialAnimesh Pardanani, Claire Harrison, Jorge E Cortes, et al.
Leukemia|June 30, 2018
LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targetingLorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Scandinavian Journal of Gastroenterology|September 17, 2005
Time-trends in the epidemiology of peptic ulcer bleedingChristian Ohmann, Michael Imhof, Christian Ruppert, et al.
Journal of Translational Autoimmunity|November 25, 2022
Autoantibodies against SUMO1-DHX35 in long-COVIDLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
European Journal of Immunology|March 31, 2021
Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patientsIgor Kos, Benedikt Balensiefer, Vadim Lesan, et al.
American Journal of Cancer Research|July 15, 2024
Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphomaTom van Meerten, John Kuruvilla, Kevin W Song, et al.
Molecular Cancer|September 28, 2024
CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patientsSylvia Zöphel, Nadja Küchler, Johanna Jansky, et al.
Nature Communications|May 20, 2020
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Cell Calcium|November 28, 2025
Fura-10, unlike fura-2, is suitable for long-term calcium imaging in natural killer (NK) cells without compromising cytotoxicity and can be combined with target cell death analysisLea Kaschek, Joanne Vialle, Gebhard Stopper, et al.
Plos One|September 7, 2022
Your best day: An interactive app to translate how time reallocations within a 24-hour day are associated with health measuresDorothea Dumuid, Timothy Olds, Melissa Wake, et al.
JAMA Oncology|July 17, 2015
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical TrialAnimesh Pardanani, Claire Harrison, Jorge E Cortes, et al.
Leukemia|June 30, 2018
LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targetingLorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Scandinavian Journal of Gastroenterology|September 17, 2005
Time-trends in the epidemiology of peptic ulcer bleedingChristian Ohmann, Michael Imhof, Christian Ruppert, et al.
Journal of Translational Autoimmunity|November 25, 2022
Autoantibodies against SUMO1-DHX35 in long-COVIDLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
European Journal of Immunology|March 31, 2021
Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patientsIgor Kos, Benedikt Balensiefer, Vadim Lesan, et al.
American Journal of Cancer Research|July 15, 2024
Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphomaTom van Meerten, John Kuruvilla, Kevin W Song, et al.
Molecular Cancer|September 28, 2024
CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patientsSylvia Zöphel, Nadja Küchler, Johanna Jansky, et al.
Nature Communications|May 20, 2020
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Pageof 12